Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Ariad Pharmaceuticals Inc. (ARIA)

7.20 Up 0.11(1.48%) Apr 17, 4:00PM EDT
|After Hours : 7.21 Up 0.01 (0.14%) Apr 17, 7:48PM EDT
Get the big picture on all your investments.
CompetitorsGet Competitors for:
Direct Competitor Comparison 
Market Cap:1.34B205.42B193.08BN/AN/A
Qtrly Rev Growth (yoy):111.880.02-0.02N/AN/A
Revenue (ttm): 45.56M58.83B51.58B182.70M1N/A
Gross Margin (ttm):-0.900.670.82N/AN/A
EBITDA (ttm):-264.63M16.20B23.12BN/AN/A
Operating Margin (ttm): -5.900.190.33N/AN/A
Net Income (ttm):-274.16M9.18B11.34B8.70M1N/A
EPS (ttm):-1.493.703.19N/AN/A
P/E (ttm):N/AN/AN/AN/AN/A
PEG (5 yr expected):-0.162.975.12N/AN/A
P/S (ttm):29.023.483.72N/AN/A
NVS = Novartis AG
PFE = Pfizer Inc.
Pvt1 = Zeltia, S.A.
1 = As of 2012  

News on Direct Competitors 

Currency in USD.